Figure 2.
Non-relapse mortality and relapse. Cumulative incidence of NRM (A) and relapse (B) after CAR-T therapy by antiepileptic prophylaxis with LVT. The type of strategy does not influence NRM or relapse rate.

Non-relapse mortality and relapse. Cumulative incidence of NRM (A) and relapse (B) after CAR-T therapy by antiepileptic prophylaxis with LVT. The type of strategy does not influence NRM or relapse rate.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal